S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
LON:ETX

e-therapeutics (ETX) Share Price, News & Analysis

GBX 11
-0.15 (-1.35%)
(As of 03/28/2024 07:39 PM ET)
Today's Range
10.65
11.49
50-Day Range
11
18.13
52-Week Range
8
24
Volume
169,640 shs
Average Volume
345,522 shs
Market Capitalization
£64.28 million
P/E Ratio
N/A
Dividend Yield
3.35%
Price Target
N/A
ETX stock logo

About e-therapeutics Stock (LON:ETX)

e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.

ETX Stock Price History

ETX Stock News Headlines

Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
e-therapeutics appoints new CFO
ETX.L - e-Therapeutics plc
Elicio Therapeutics Inc.
8-K: Seres Therapeutics, Inc.
e-Therapeutics plc (ETX.L)
See More Headlines
Receive ETX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for e-therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/17/2020
Today
3/29/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
34
Year Founded
N/A

Profitability

Net Income
£-10,060,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£295,000.00
Cash Flow
GBX 2.17 per share
Book Value
GBX 5 per share

Miscellaneous

Free Float
N/A
Market Cap
£64.28 million
Optionable
Not Optionable
Beta
0.48
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Ahmad Ali Mortazavi (Age 53)
    CEO & Director
    Comp: $270k
  • Mr. Timothy Bretherton
    CFO, Director of Finance & Operations and Company Secretary
  • Dr. Laura Roca-Alonso Ph.D.
    Chief Operating Officer
  • Mr. Alan Whitmore B.Sc.
    Ph.D., Chief Scientific Officer
  • Mr. Ankit Sharma
    Head of Software Engineering
  • Mr. Graham Craggs
    Head of Therapeutic Discovery

ETX Stock Analysis - Frequently Asked Questions

How have ETX shares performed in 2024?

e-therapeutics' stock was trading at GBX 8.24 at the beginning of the year. Since then, ETX stock has increased by 33.5% and is now trading at GBX 11.
View the best growth stocks for 2024 here
.

How were e-therapeutics' earnings last quarter?

e-therapeutics plc (LON:ETX) posted its quarterly earnings data on Tuesday, March, 17th. The company reported ($0.87) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.03.

What other stocks do shareholders of e-therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other e-therapeutics investors own include Radware (RDWR), Sound Energy (SOU), 4D pharma (DDDD), Chicken Soup for the Soul Entertainment (CSSE), Crescent Point Energy (CPG), Collagen Solutions plc (COS.L) (COS), BP (BP), Bushveld Minerals (BMN) and Alstom (ALSMY).

How do I buy shares of e-therapeutics?

Shares of ETX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ETX) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners